[HTML][HTML] Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer
M Milani, S Venturini, S Bonardi, G Allevi, C Strina… - Oncotarget, 2017 - ncbi.nlm.nih.gov
M Milani, S Venturini, S Bonardi, G Allevi, C Strina, MR Cappelletti, SP Corona, S Aguggini…
Oncotarget, 2017•ncbi.nlm.nih.govHypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness
and resistance in locally advanced breast cancer - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List
Oncotarget v.8(45); 2017 Oct 3 PMC5668004 Other Formats PDF (3.5M) Actions Cite Collections
Share Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
and resistance in locally advanced breast cancer - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List
Oncotarget v.8(45); 2017 Oct 3 PMC5668004 Other Formats PDF (3.5M) Actions Cite Collections
Share Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Abstract
Purpose
To identify hypoxia-related biomarkers indicative of response and resistance to epirubicin treatment in patients with locally advanced breast cancer.
ncbi.nlm.nih.gov
